| usfdaEstimatingMaximumSafe2018 | USFDA. “Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers.” FDA, December 1, 2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/estimating-maximum-safe-starting-dose-initial-clinical-trials-therapeutics-adult-healthy-volunteers. |
| linUrolithinAinducedMitophagy2020 | Lin, Jialiang, Jinru Zhuge, Xuanqi Zheng, Yuhao Wu, Zengjie Zhang, Tianzhen Xu, Zaher Meftah, et al. “Urolithin A-Induced Mitophagy Suppresses Apoptosis and Attenuates Intervertebral Disc Degeneration via the AMPK Signaling Pathway.” Free Radical Biology & Medicine 150 (April 2020): 109–19. https://doi.org/10.1016/j.freeradbiomed.2020.02.024. |
| liuUrolithinInhibitsCatabolic2018 | Liu, Huiyong, Honglei Kang, Chao Song, Zuowei Lei, Li Li, Jianfeng Guo, Yong Xu, Hanfeng Guan, Zhong Fang, and Feng Li. “Urolithin A Inhibits the Catabolic Effect of TNFα on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in Vivo.” Frontiers in Pharmacology 9 (2018): 1043. https://doi.org/10.3389/fphar.2018.01043. |
| shiUrolithinAlleviatesOxidative2021 | Shi, Peng-Zhi, Jun-Wu Wang, Ping-Chuan Wang, Bo Han, Xu-Hua Lu, Yong-Xin Ren, Xin-Min Feng, Xiao-Fei Cheng, and Liang Zhang. “Urolithin a Alleviates Oxidative Stress-Induced Senescence in Nucleus Pulposus-Derived Mesenchymal Stem Cells through SIRT1/PGC-1α Pathway.” World Journal of Stem Cells 13, no. 12 (December 26, 2021): 1928–46. https://doi.org/10.4252/wjsc.v13.i12.1928. |